Wednesday, July 8, 2026

pharma · Paroxysmal Nocturnal Hemoglobinuria (PNH) · Paroxysmal Nocturnal Haemoglobinuria (PNH) · AKTX

Akari Therapeutics

Akari Therapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

London, GB HQ
16 Employees
Public company Type
AKTX · NYSE Ticker
Company details
Status
Public
HQ
London, GB
Employees
16
Programs
9
Drugs
0
Patents
0
Intelligence · Clinical Trials

Akari Therapeutics clinical trials

Registry index of 9 ClinicalTrials.gov studies linked to Akari Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Akari Therapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Akari Therapeutics.

  1. nomacopan (rVA576) — Phase 3

    Clinical update
  2. nomacopan (rVA576) — Phase 3

    Clinical update
  3. rVA576 — Phase 3

    Clinical update
  4. rVA576 — Phase 3

    Clinical update
  5. Coversin — Phase 2

    Clinical update
  6. Coversin — Phase 2

    Clinical update
  7. MRX-6 — Phase 2

    Clinical update
  8. rVA576 — Phase 2

    Clinical update

Trial registry

9 studies